A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...
A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...
People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...
Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...
A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...
Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with ...
Patients with cutaneous lupus erythematosus may be at an increased risk for atherosclerotic cardiovascular disease, even more ...
Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback